Weed (BUDZ) Research & Development (2010 - 2012)

Weed's (BUDZ) quarterly Research & Development came in at $1359.0 in Q1 2012, down 89.51% quarter-over-quarter from $12950.0 in Q4 2011.

Weed (BUDZ) Research & Development (2010 - 2012) Analysis & Trends

Weed's Research & Development history runs 3 years deep, the most recent figure standing at $1359.0 for Q1 2012.

  • On a quarterly basis, Research & Development changed N/A year-over-year to $1359.0 in Q1 2012; TTM through Mar 2012 was $30369.0, a N/A change from a year earlier, with the FY2011 full-year figure at $12950.0, down 67.78% from the prior year.
  • Research & Development fell to $1359.0 in Q1 2012 per BUDZ's latest filing, from $12950.0 in the prior quarter.
  • Across five years, Research & Development topped out at $40187.0 in Q4 2010 and bottomed at $1359.0 in Q1 2012.
  • The 3-year median for Research & Development is $14505.0 (2011), against an average of $17639.0.
  • Biggest YoY gain for Research & Development was 67.78% in 2011; the steepest drop was 67.78% in 2011.
  • Year by year, Research & Development stood at $40187.0 in 2010, then sank by 67.78% to $12950.0 in 2011, then tumbled by 89.51% to $1359.0 in 2012.
  • Per Business Quant, the three latest BUDZ Research & Development figures stand at $1359.0 (Q1 2012), $12950.0 (Q4 2011), and $16060.0 (Q3 2011).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 696.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 180.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 7.37 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 138.20 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 248.60 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 296.20 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 97.00 Mn
10 Weed 3.72 Mn 3.72 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2012 1,359.00
Dec 31, 2011 12,950.00
Sep 30, 2011 16,060.00
Dec 31, 2010 40,187.00